 |
Medscape Conference Coverage, based on selected sessions at the: Second International AIDS Society Conference on HIV Pathogenesis and Treatment July 13 - 16, 2003, Paris, France
  | Medscape is the official provider of online conference coverage and continuing medical education activities based on the
Second IAS Conference on HIV Pathogenesis and Treatment. |
|
| Topic Overviews | |
| Antiretroviral Therapy and Therapeutic Strategies CMEPhysicians - up to 1.5 hour(s) of AMA PRA category 1 credit
Pharmacists - up to 1.5 contact hour(s) (0.15 CEUs)
 New and Investigational Antiretroviral Drugs Mark A. Wainberg, PhD Treatment Failure and Antiretroviral Management of Treatment-Experienced Patients Julio S.G. Montaner, MD, FRCP Marianne Harris, MD Novel Treatment Strategies Douglas J. Ward, MD HIV Drug Resistance and Pharmacology CMEPhysicians - up to 1.0 hour(s) of AMA PRA category 1 credit
Pharmacists - up to 1.0 contact hour(s) (0.1 CEUs)
Antiretroviral Drug Resistance and Viral Fitness Stefano Vella, MD Advances in the Clinical Pharmacology of Antiretroviral Therapy Praphan Phanuphak, MD, PhD Complications of HIV Disease and Therapy CMEPhysicians - up to 1.0 hour(s) of AMA PRA category 1 credit
Pharmacists - up to 1.0 contact hour(s) (0.1 CEUs)
Etiology and Management of Morphologic Changes Associated With HIV Infection and Antiretroviral Therapy (includes an update from the 5th International Workshop on Adverse Reactions and Lipodystrophy in HIV) Graeme J. Moyle, MD, MBBS Antiretroviral Influences on Atherosclerosis and Fat Metabolism (includes an update from the 5th International Workshop on Adverse Reactions and Lipodystrophy in HIV) Mark A. Wainberg, PhD Opportunistic Infections: Little Attention to the Big Killers Pedro Cahn, MD, PhD Pathogenesis of HIV Infection CMEPhysicians - up to 0.5 hour(s) of AMA PRA category 1 credit
Virus and Host Factors in HIV Pathogenesis Jay A. Levy, MD HIV Immunopathogenesis and Correlates of Protection Bruce Walker, MD HIV Disease in Children CMEPhysicians - up to 0.5 hour(s) of AMA PRA category 1 credit
Treatment of HIV Infection in Children Stephane Blanche, MD |
| Expert Commentary and Interviews | |
| This Just in... Late-Breaker Session 1July 17, 2003 Read about primary drug resistance, switch therapy, preventing mother-to-child HIV transmission via breastfeeding, and more in this roundup of late breakers from Brian Conway, MD. Expert Commentary: Viral Dynamics and FitnessJuly 15, 2003 Mark A. Wainberg, PhD, comments on the session discussing viral dynamics and fitness. It is clear that advances in these areas, notably receptor usage, viral quantification, and genetic diversity, will influence treatment in the near future. Expert Commentary: HIV Drug Resistance UpdateJuly 14, 2003 Mark A. Wainberg, PhD, provides an insightful overview of new data and evolving knowledge pertaining to the development, detection, and clinical significance of antiretroviral drug resistance. Expert Commentary: Opening CeremonyJuly 13, 2003, Paris Mark A. Wainberg, PhD, comments on the opening session of IAS 2003. The message: expanding antiretroviral drug access in the developing world is a moral, ethical, and economic imperative following 20 years of advances in the study and treatment of HIV disease in the United States and Europe. |
| Downloads | |
| Downloadable PowerPoint Slide Set: Please note: in order to download the Power Point presentation, click on the link above (you may have to Right-Click) to obtain the menu box. Utilize the menu box (i.e. Save Target As...) to save the presentation to your hard-drive. |
| | | Selected Posters & Abstracts Coverage | |
| International Perspectives | |
| Developed in collaboration with our international partners.  Canada MexicoSelected Translations |
| Daily Conference News from Medscape HIV/AIDS | |
| Read daily conference news from Medscape Medical News, Reuters Health, and World AIDS News. |
| 20 Years of HIV Science | |
| The following articles are part of a Nature Medicine special issue, "20 Years of HIV Science." The entire issue is available free for a limited time on the Nature Medicine Web site. |
|
| Special Presentations: Keynotes, Plenary Addresses, and Selected Sessions | |
| Wednesday, July 16, 2003 Main Plenary View WebcastChairs: Jean-François Delfraissy and Douglas Richman HIV Entry: Insights Into Viral Tropism, Pathogenesis, and Antiviral Therapy Robert Doms
University of Pennsylvania, Philadelphia Mechanisms and Management of Metabolic Complications Associated With Highly Active Antiretroviral TherapyPeter Reiss
Academic Medical Center, University of Amsterdam, The NetherlandsClosing Ceremony View Webcast Tuesday, July 15, 2003 Main Plenary View WebcastChairs: Christine Katlama and Giuseppe Pantaleo New Antiretroviral Drugs and Therapeutic StrategiesPatrick Yeni
Hospital Bichat, Paris, France HIV Vaccine Research: The State of the ScienceLawrence CoreyUniversity of Washington, SeattleControversy: There Is More Risk Than Value in Treatment Interruptions View WebcastForum: The Scaling-up of Antiretroviral Therapy in Developing Countries View Webcast Update on the Use of Antiretrovirals in Countries With Limited Resources: From Pilot Studies to Public Health RealitiesPapa Salif SowDakar University Teaching Hospital, Senegal The Challenges of Expanding Access to Antiretrovirals WorldwidePaulo TeixeiraBrazilian STD/AIDS Program, Ministry of Health, Brasilia, BrazilAdditional Forum participants: Sanjay Pujari, E. Shutes, Sarah A. Adomakoh, and N. Durier. Monday, July 14, 2003 Main Plenary View WebcastRead TranscriptChairs: Françoise Barré-Sinoussi and Souleymane Mboup Challenges and Lessons Learned in Implementing Antiretroviral Therapy in the Developing World
Ernest Darkoh
Ministry of Health, Gaborone, Botswana
Host/Virus Mechanisms in the Molecular Pathogenesis of HIV
Nathaniel R. Landau
The Salk Institute for Biological Studies, San Diego, California
Extraordinary Plenary: 20 Years of HIV Science
View Webcast
Read Transcript
Chairs: Robert C. Gallo, Institute of Human Virology, University of Maryland, Baltimore; and Luc Montagnier, Fondation Mondiale Recherche et Prevention SIDA, Paris, France.
Keynote lecture
20 Years of HIV Science
Anthony Fauci
Director NIAID, NIH, Bethesda, Maryland Keynote address
From Science to Action: Challenges in Managing AIDS
Nelson Mandela
Former President of South Africa Sunday, July 13, 2003 Chairs: Michel Kazatchikine and Joep Lange. Bertrand Delanoe, Mayor of Paris, also speaks. Keynote opening address Building a State-Civil Society Alliance to Fight AIDS: The Brazilian ExperienceFernando Henrique Cardoso, former President of Brazil Keynote lecture Expanding Access to Antiretroviral Treatment in the Developing World: The Economic RationaleJean-Paul MoattiUniversity of the Mediterranean, Marseille, France Community address Where Is the War Chest Against AIDS?Marie-Josée MbuzenakamweAssociation Nationale de Soutien aux Séropositifs et Sidéens (ANSS), Bujumbura, Burundi |
|
| Legal Disclaimer | |
| The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the International AIDS Society. These materials and the related activity are not sanctioned by the International AIDS Society or the commercial supporter of the conference, and do not constitute an official part of that conference. The material presented here does not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2003 Medscape. |
|
|
|
